Results
|
|
40381.
|
|
|
|
40382.
|
|
|
|
40383.
|
|
|
|
40384.
|
|
|
|
40385.
|
|
|
|
40386.
|
|
|
|
40387.
|
|
|
|
40388.
|
|
|
|
40389.
|
|
|
|
40390.
|
|
|
|
40391.
|
|
|
|
40392.
|
|
|
|
40393.
|
|
|
|
40394.
|
|
|
|
40395.
|
|
|
|
40396.
|
|
|
|
40397.
|
|
|
|
40398.
|
|
|
|
40399.
|
|
|
|
40400.
|
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). [electronic resource] by
- Papp, Kim A
- Langley, Richard G
- Lebwohl, Mark
- Krueger, Gerald G
- Szapary, Philippe
- Yeilding, Newman
- Guzzo, Cynthia
- Hsu, Ming-Chun
- Wang, Yuhua
- Li, Shu
- Dooley, Lisa T
- Reich, Kristian
Producer: 20080527
In:
Lancet (London, England) vol. 371
Availability: No items available.
|